Sterilisation deaths spotlight India's drug safety record
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
New Delhi
THE deaths of 13 Indian women allegedly given tainted antibiotics after undergoing sterilisation surgery have raised fresh questions about India's giant drug industry, already under international scrutiny over its troubled safety record. India exports US$15 billion in over-the-counter and generic prescription drugs annually and is the second-largest supplier of drugs to the United States after Canada, earning it the title of "pharmacy to the world". But some of its biggest pharmaceutical companies such as Sun Pharma, Ranbaxy and Wockhardt have faced a string of US import bans over quality concerns.
The US Food and Drug Administration (FDA) has in the past few years banned generic versions of popular medicines such as the acne drug Accutane, the anti-pain medicine Neurontin and the antibiotic Cipro after the agency's investigators determined they were adulterated.
Share with us your feedback on BT's products and services
